show help

Balzarini J

Author page

This page provides a summary of the entries in Polbase associated with this author.

The publication history graph presents the number of publications in Polbase by this author over time.

The polymerase chart indicates which polymerases this author has published on.

Polbase automatically discovers many polymerase papers as they are published. Some relevant papers are not included because the algorithm is designed to reduce background. Please contribute to polbase by adding your missing DNA polymerase papers.

Help icons:

The show help symbol in the upper-right corner of the page links to this help text. The question mark icon is used everywhere to indicate that help is available.

Missing references?

Publications:

Title Authors Year Journal
N-3 substituted TSAO derivatives as a probe to explore the dimeric interface of HIV-1 reverse transcriptase. Balzarini J Nucleosides, nucleotides & nucleic acids
Towards new C6-rigid S-DABO HIV-1 reverse transcriptase inhibitors: Synthesis, biological investigation and molecular modeling studies. Balzarini J 2013 Bioorganic & medicinal chemistry
Novel piperidinylamino-diarylpyrimidine derivatives with dual structural conformations as potent HIV-1 non-nucleoside reverse transcriptase inhibitors. Balzarini J 2013 Bioorganic & medicinal chemistry letters
Design, Synthesis, and Biological Evaluation of Novel 3,5-Disubstituted-1,2,6-Thiadiazine-1,1-Dione Derivatives as HIV-1 NNRTIs. Balzarini J 2013 Chemical biology & drug design
A Multi-targeted Drug Candidate with Dual Anti-HIV and Anti-HSV Activity. Balzarini J 2013 PLoS pathogens
Discovery of Piperidine-Linked Pyridine Analogues as Potent Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors. Balzarini J 2013 ChemMedChem
N(1),N(3)-disubstituted uracils as nonnucleoside inhibitors of HIV-1 reverse transcriptase. Balzarini J 2013 Bioorganic & medicinal chemistry
Synthesis and biological evaluation of pyridazine derivatives as novel HIV-1 NNRTIs. Balzarini J 2013 Bioorganic & medicinal chemistry
Recent advances in thymidine kinase 2 (TK2) inhibitors and new perspectives for potential applications. Balzarini J 2012 Current pharmaceutical design
Chiral resolution, absolute configuration assignment and biological activity of racemic diarylpyrimidine CH(OH)-DAPY as potent nonnucleoside HIV-1 reverse transcriptase inhibitors. Balzarini J 2012 European journal of medicinal chemistry
Arylazolylthioacetanilide. Part 11: Design, Synthesis and Biological Evaluation of 1,2,4-Triazole Thioacetanilide Derivatives as Novel Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors. Balzarini J 2012 Medicinal chemistry (Shāriqah (United Arab Emirates))
In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs. Balzarini J 2012 Journal of virology
Potential of carbohydrate-binding agents as therapeutics against enveloped viruses. Balzarini J 2012 Medicinal research reviews
Exploiting the anti-HIV-1 activity of acyclovir: suppression of primary and drug-resistant HIV isolates and potentiation of the activity by ribavirin. Balzarini J 2012 Antimicrobial agents and chemotherapy
Synthesis and biological evaluation of piperidine-substituted triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors. Balzarini J 2012 European journal of medicinal chemistry
Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication. Balzarini J 2011 Cell host & microbe
Indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: new cyclic substituents at indole-2-carboxamide. Balzarini J 2011 Journal of medicinal chemistry
Selective inhibition of Human Immunodeficiency Virus type 1 (HIV-1) by a novel family of tricyclic nucleosides. Balzarini J 2011 Antiviral research
Crystal structure of tert-butyldimethylsilyl-spiroaminooxathioledioxide-thymine (TSAO-T) in complex with HIV-1 reverse transcriptase (RT) redefines the elastic limits of the non-nucleoside inhibitor-binding pocket. Balzarini J 2011 Journal of medicinal chemistry
1-[2-(2-Benzoyl- and 2-benzylphenoxy)ethyl]uracils as potent anti-HIV-1 agents. Balzarini J 2011 Bioorganic & medicinal chemistry
Synthesis and anti-HIV activity of aryl-2-[(4-cyanophenyl)amino]-4-pyrimidinone hydrazones as potent non-nucleoside reverse transcriptase inhibitors. Balzarini J 2011 ChemMedChem
Novel antiviral C5-substituted pyrimidine acyclic nucleoside phosphonates selected as human thymidylate kinase substrates. Balzarini J 2011 Journal of medicinal chemistry
Hybrid diarylbenzopyrimidine non-nucleoside reverse transcriptase inhibitors as promising new leads for improved anti-HIV-1 chemotherapy. Balzarini J 2010 Bioorganic & medicinal chemistry
Synthesis and biological evaluation of 4-(hydroxyimino)arylmethyl diarylpyrimidine analogues as potential non-nucleoside reverse transcriptase inhibitors against HIV. Balzarini J 2010 Bioorganic & medicinal chemistry
Lead optimization of diarylpyrimidines as non-nucleoside inhibitors of HIV-1 reverse transcriptase. Balzarini J 2010 ChemMedChem
The acyclic 2,4-diaminopyrimidine nucleoside phosphonate acts as a purine mimetic in HIV-1 reverse transcriptase DNA polymerization. Balzarini J 2010 The Journal of biological chemistry
Synthesis and anti-HIV activity of 2-naphthyl substituted DAPY analogues as non-nucleoside reverse transcriptase inhibitors. Balzarini J 2010 Bioorganic & medicinal chemistry
Indolylarylsulfones bearing natural and unnatural amino acids. Discovery of potent inhibitors of HIV-1 non-nucleoside wild type and resistant mutant strains reverse transcriptase and coxsackie B4 virus. Balzarini J 2009 Journal of medicinal chemistry
Mechanisms associated with HIV-1 resistance to acyclovir by the V75I mutation in reverse transcriptase. Balzarini J 2009 The Journal of biological chemistry
Synthesis and in vitro anti-HIV evaluation of a new series of 6-arylmethyl-substituted S-DABOs as potential non-nucleoside HIV-1 reverse transcriptase inhibitors. Balzarini J 2009 European journal of medicinal chemistry
The application of phosphoramidate protide technology to acyclovir confers anti-HIV inhibition. Balzarini J 2009 Journal of medicinal chemistry
Design, synthesis, and SAR of naphthyl-substituted Diarylpyrimidines as non-nucleoside inhibitors of HIV-1 reverse transcriptase. Balzarini J 2009 ChemMedChem
Non-nucleoside reverse transcriptase inhibitors (Part 18): synthesis and anti-HIV activity of 4-allylamino or 4-azido substituted diaryltriazines. Balzarini J 2009 Yao xue xue bao = Acta pharmaceutica Sinica
Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 13: synthesis of fluorine-containing diaryltriazine derivatives for in vitro anti-HIV evaluation against wild-type strain. Balzarini J 2009 Chemistry & biodiversity
Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 11: structural modulations of diaryltriazines with potent anti-HIV activity. Balzarini J 2008 European journal of medicinal chemistry
Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues. Balzarini J 2008 Cell Host Microbe
Non-nucleoside HIV-1 reverse-transcriptase inhibitors. Part 10. Synthesis and anti-HIV activity of 5-alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a mono- or disubstituted 2-amino function as novel 'dihydro-alkoxy-benzyl-oxopyrimidine' (DABO) analogues. Balzarini J 2008 Chemistry & biodiversity
Synthesis and biological evaluation of novel 6-substituted 5-alkyl-2-(arylcarbonylmethylthio)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors. Balzarini J 2008 Bioorganic & medicinal chemistry
Activity of the small modified amino acid alpha-hydroxy glycineamide on in vitro and in vivo human immunodeficiency virus type 1 capsid assembly and infectivity. Balzarini J 2008 Antimicrobial agents and chemotherapy
4"-Benzoylureido-TSAO derivatives as potent and selective non-nucleoside HCMV inhibitors. Structure-activity relationship and mechanism of antiviral action. Balzarini J 2008 Journal of medicinal chemistry
Synthesis and anti-HIV activity evaluation of 1-[(alkenyl or alkynyl or alkyloxy)methyl]-5-alkyl-6-(1-naphthoyl)-2,4-pyrimidinediones as novel non-nucleoside HIV-1 reverse transcriptase inhibitors. Balzarini J 2007 European journal of medicinal chemistry
Novel non-nucleoside human cytomegalovirus inhibitors based upon TSAO nucleoside derivatives: structure-activity relationships. Balzarini J 2007 Nucleosides, nucleotides & nucleic acids
Antiviral activity of 3-(3,5-dimethylbenzyl)uracil derivatives against HIV-1 and HCMV. Balzarini J 2007 Nucleosides, nucleotides & nucleic acids
Comparative evaluation of the activity of antivirals towards feline immunodeficiency virus in different cell culture systems. Balzarini J 2007 Antiviral research
Discovery of novel benzimidazolones as potent non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains. Balzarini J 2007 Bioorganic & medicinal chemistry letters
Synthesis and anti-HIV-1 activity evaluation of 5-alkyl-2-alkylthio-6-(arylcarbonyl or alpha-cyanoarylmethyl)-3,4-dihydropyrimidin-4(3H)-ones as novel non-nucleoside HIV-1 reverse transcriptase inhibitors. Balzarini J 2007 Journal of medicinal chemistry
Synthesis and anti-HIV studies of 2-adamantyl-substituted thiazolidin-4-ones. Balzarini J 2007 European journal of medicinal chemistry
Synthesis and anti-HIV-1 and anti-HCMV activity of 1-substituted 3-(3,5-dimethylbenzyl)uracil derivatives. Balzarini J 2006 Chemical & pharmaceutical bulletin
Therapeutic strategies towards HIV-1 infection in macrophages. Balzarini J 2006 Antiviral research
Structure-activity relationships of [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]- 3'-spiro-5' '-(4' '-amino-1' ',2' '-oxathiole-2' ',2' '-dioxide)thymine derivatives as inhibitors of HIV-1 reverse transcriptase dimerization. Balzarini J 2006 Journal of medicinal chemistry
Non-nucleoside HIV-1 reverse transcriptase inhibitors, Part 7. Synthesis, antiviral activity, and 3D-QSAR investigations of novel 6-(1-naphthoyl) HEPT analogues. Balzarini J 2006 Chemical & pharmaceutical bulletin
Nonnucleoside HIV-1 reverse-transcriptase inhibitors, part 5. Synthesis and anti-HIV-1 activity of novel 6-naphthylthio HEPT analogues. Balzarini J 2005 Chemical & pharmaceutical bulletin
Non-nucleoside HIV reverse transcriptase inhibitors, Part 6[1]: synthesis and anti-HIV activity of novel 2-[(arylcarbonylmethyl)thio]-6-arylthio DABO analogues. Balzarini J 2005 Archiv der Pharmazie
High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations. Balzarini J 2005 Journal of virology
First synthesis and evaluation of the inhibitory effects of aza analogues of TSAO on HIV-1 replication. Balzarini J 2005 Journal of medicinal chemistry
The role of Thr139 in the human immunodeficiency virus type 1 reverse transcriptase sensitivity to (+)-calanolide A. Balzarini J 2005 Molecular pharmacology
The molecular basis of resilience to the effect of the Lys103Asn mutation in non-nucleoside HIV-1 reverse transcriptase inhibitors studied by targeted molecular dynamics simulations. Balzarini J 2005 Journal of the American Chemical Society
The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs. Balzarini J 2005 FEBS letters
The amino acid Asn136 in HIV-1 reverse transcriptase (RT) maintains efficient association of both RT subunits and enables the rational design of novel RT inhibitors. Balzarini J 2005 Molecular pharmacology
Susceptibilities of several clinical varicella-zoster virus (VZV) isolates and drug-resistant VZV strains to bicyclic furano pyrimidine nucleosides. Balzarini J 2005 Antimicrobial agents and chemotherapy
Antiadenovirus activities of several classes of nucleoside and nucleotide analogues. Balzarini J 2005 Antimicrobial agents and chemotherapy
Marked depletion of glycosylation sites in HIV-1 gp120 under selection pressure by the mannose-specific plant lectins of Hippeastrum hybrid and Galanthus nivalis. Balzarini J 2005 Molecular pharmacology
Pyridine N-oxide derivatives: unusual anti-HIV compounds with multiple mechanisms of antiviral action. Balzarini J 2005 The Journal of antimicrobial chemotherapy
Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1. Balzarini J 2004 Current topics in medicinal chemistry
In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides. Balzarini J 2004 Antimicrobial agents and chemotherapy
The phenylmethylthiazolylthiourea nonnucleoside reverse transcriptase (RT) inhibitor MSK-076 selects for a resistance mutation in the active site of human immunodeficiency virus type 2 RT. Balzarini J 2004 Journal of virology
Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors. Balzarini J 2004 Molecular pharmacology
Nonnucleoside HIV-1 reverse transcriptase inhibitors; part 3. Synthesis and antiviral activity of 5-alkyl-2-[(aryl and alkyloxyl-carbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones. Balzarini J 2004 Bioorganic chemistry
2-(2,6-Dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors. Balzarini J 2004 Antiviral research
5-Alkyl-2-[(aryl and alkyloxylcarbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones as an unique HIV reverse transcriptase inhibitors of S-DABO series. Balzarini J 2004 Bioorganic & medicinal chemistry letters
Antiviral profile of HIV inhibitors in macrophages: implications for therapy. Balzarini J 2004 Current topics in medicinal chemistry
TSAO compounds: the comprehensive story of a unique family of HIV-1 specific inhibitors of reverse transcriptase. Balzarini J 2004 Current topics in medicinal chemistry
Synthesis of new 2,3-diaryl-1,3-thiazolidin-4-ones as anti-HIV agents. Balzarini J 2004 Farmaco (Società chimica italiana : 1989)
Synthesis and antiviral activity of 1,3-disubstituted uracils against HIV-1 and HCMV. Balzarini J 2003 Antiviral chemistry & chemotherapy
Structure-activity relationship studies on a novel family of specific HIV-1 reverse transcriptase inhibitors. Balzarini J 2003 Antiviral chemistry & chemotherapy
A conformationally locked analogue of the anti-HIV agent stavudine. An important correlation between pseudorotation and maximum amplitude. Balzarini J 2003 Journal of medicinal chemistry
N-aminoimidazole derivatives inhibiting retroviral replication via a yet unidentified mode of action. Balzarini J 2003 Journal of medicinal chemistry
Characterization of the catalytic subunit of the human herpesvirus 6 (HHV-6) DNA polymerase expressed in an in vitro transcription/translation assay. Balzarini J 2003 Nucleosides, nucleotides & nucleic acids
Deoxyribonucleoside 2'- or 3'-mixed disulfides: prodrugs to target ribonucleotide reductase and/or to inhibit HIV reverse transcription. Balzarini J 2003 Journal of medicinal chemistry
Nonnucleoside HIV-1 reverse transcriptase inhibitors: Part I. Synthesis and structure-activity relationship of 1-alkoxymethyl-5-alkyl-6-naphthylmethyl uracils as HEPT analogues. Balzarini J 2003 Chemical & pharmaceutical bulletin
Inhibition of human immunodeficiency virus by a new class of pyridine oxide derivatives. Balzarini J 2003 Antimicrobial agents and chemotherapy
Novel human immunodeficiency virus (HIV) inhibitors that have a dual mode of anti-HIV action. Balzarini J 2003 Antimicrobial agents and chemotherapy
Synthesis, solution conformation and anti-HIV activity of novel 3'-substituted-2',3'-dideoxy-5-hydroxymethyluridines and their 4,5-substituted analogues. Balzarini J 2003 Antiviral chemistry & chemotherapy
Synthesis and antiviral activity of some 5'-N-phthaloyl-3'-azido-2',3'-dideoxythymidine analogues. Balzarini J 2003 Antiviral chemistry & chemotherapy
Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir. Balzarini J 2002 Antiviral research
Metabolic activation of nucleoside and nucleotide reverse transcriptase inhibitors in dendritic and Langerhans cells. Balzarini J 2002 AIDS (London, England)
Activity of reverse transcriptase inhibitors in monocyte-derived dendritic cells: a possible in vitro model for postexposure prophylaxis of sexual HIV transmission. Balzarini J 2002 AIDS research and human retroviruses
Synthesis of 3' '-substituted TSAO derivatives with anti-HIV-1 and anti-HIV-2 activity through an efficient palladium-catalyzed cross-coupling approach. Balzarini J 2002 Journal of medicinal chemistry
Chemotherapy of varicella-zoster virus by a novel class of highly specific anti-VZV bicyclic pyrimidine nucleosides. Balzarini J 2002 Biochimica et biophysica acta
Chimeric human immunodeficiency virus type 1 and feline immunodeficiency virus reverse transcriptases: role of the subunits in resistance/sensitivity to non-nucleoside reverse transcriptase inhibitors. Balzarini J 2002 Molecular pharmacology
Exploitation of the low fidelity of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase and the nucleotide composition bias in the HIV-1 genome to alter the drug resistance development of HIV. Balzarini J 2001 Journal of virology
Synthesis, biological activity, pharmacokinetic properties and molecular modelling studies of novel 1H,3H-oxazolo[3,4-a]benzimidazoles: non-nucleoside HIV-1 reverse transcriptase inhibitors. Balzarini J 2001 Antiviral chemistry & chemotherapy
Rapid alternation of drug therapy is highly efficient in suppressing the emergence of mutant drug-resistant HIV strains in cell culture. Balzarini J 2001 AIDS research and human retroviruses
Anti-HIV-1 activity of benzothiadiazine dioxide. Balzarini J 2001 Antiviral chemistry & chemotherapy
Identification of a novel family of nucleosides that specifically inhibit HIV-1 reverse transcriptase. Balzarini J 2001 Bioorganic & medicinal chemistry letters
Mutations at amino acid positions 63, 189, and 396 of human immunodeficiency virus type 1 reverse transcriptase (RT) partially restore the DNA polymerase activity of a Trp229Tyr mutant RT. Balzarini J 2001 Virology
Identification of a putative binding site for [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine (TSAO) derivatives at the p51-p66 interface of HIV-1 reverse transcriptase. Balzarini J 2001 Journal of medicinal chemistry
Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138. Balzarini J 2001 Virology
Mutational analysis of trp-229 of human immunodeficiency virus type 1 reverse transcriptase (RT) identifies this amino acid residue as a prime target for the rational design of new non-nucleoside RT inhibitors. Balzarini J 2000 Molecular pharmacology
Partial purification and characterization of mitochondrial DNA polymerase from Plasmodium falciparum. Balzarini J 2000 Parasitol Int
Long-term exposure of HIV type 1-infected cell cultures to combinations of the novel quinoxaline GW420867X with lamivudine, abacavir, and a variety of nonnucleoside reverse transcriptase inhibitors. Balzarini J 2000 AIDS research and human retroviruses
Phenylethylthiazolylthiourea (PETT) non-nucleoside inhibitors of HIV-1 and HIV-2 reverse transcriptases. Structural and biochemical analyses. Balzarini J 2000 The Journal of biological chemistry
Anti-(herpes simplex virus) activity of 4'-thio-2'-deoxyuridines: a biochemical investigation for viral and cellular target enzymes. Balzarini J 2000 The Biochemical journal
Evaluation of Compounds Against Recombinant HIV Reverse Transcriptase. Balzarini J 2000 Methods in molecular medicine
Evaluating Clinical Isolates for Their Phenotypic and Genotypic Resistance Against Anti-HIV Drugs. Balzarini J 2000 Methods in molecular medicine
Human immunodeficiency virus type 1 reverse transcriptase dimer destabilization by 1-[Spiro[4"-amino-2",2" -dioxo-1",2" -oxathiole-5",3'-[2', 5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]]]-3-ethylthy mine. Balzarini J 2000 Biochemistry
Presence of 2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5"-(4"-amino-1",2"-oxath iole-2",2"-dioxide) (TSAO)-resistant virus strains in TSAO-inexperienced HIV patients. Balzarini J 2000 AIDS research and human retroviruses
Suppression of resistance to drugs targeted to human immunodeficiency virus reverse transcriptase by combination therapy. Balzarini J 1999 Biochemical pharmacology
Synthesis and anti-HIV activity of 1,1,3-trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazines (TTDs): a new family of HIV-1 specific non-nucleoside reverse transcriptase inhibitors. Balzarini J 1999 Bioorganic & medicinal chemistry
Potential multifunctional inhibitors of HIV-1 reverse transcriptase. Novel [AZT]-[TSAO-T] and [d4T]-[TSAO-T] heterodimers modified in the linker and in the dideoxynucleoside region. Balzarini J 1999 Journal of medicinal chemistry
Role of antimetabolites of purine and pyrimidine nucleotide metabolism in tumor cell differentiation. Balzarini J 1999 Biochemical pharmacology
9-(2-Phosphonylmethoxyethyl)adenine induces tumor cell differentiation or cell death by blocking cell cycle progression through the S phase. Balzarini J 1999 Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research
A proline-to-histidine substitution at position 225 of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) sensitizes HIV-1 RT to BHAP U-90152. Balzarini J 1998 The Journal of general virology
Crystal structures of HIV-1 reverse transcriptase in complex with carboxanilide derivatives. Balzarini J 1998 Biochemistry
Treatment of visna virus infection in lambs with the acyclic nucleoside phosphonate analogue 9-(2-phosphonylmethoxyethyl)adenine (PMEA). Balzarini J 1998 Antiviral chemistry & chemotherapy
An approach towards the synthesis of potential metal-chelating TSAO-T derivatives as bidentate inhibitors of human immunodeficiency virus type 1 reverse transcriptase. Balzarini J 1998 Antiviral chemistry & chemotherapy
Abasic analogues of TSAO-T as the first sugar derivatives that specifically inhibit HIV-1 reverse transcriptase. Balzarini J 1998 Journal of medicinal chemistry
Novel 1,1,3-trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine derivatives as non-nucleoside reverse transcriptase inhibitors that inhibit human immunodeficiency virus type 1 replication. Balzarini J 1998 Journal of medicinal chemistry
1,1,3-Trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine (TTD) derivatives: a new class of nonnucleoside human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitors with anti-HIV-1 activity. Balzarini J 1998 Antimicrobial agents and chemotherapy
Zidovudine-resistant human immunodeficiency virus type 1 strains subcultured in the presence of both lamivudine and quinoxaline HBY 097 retain marked sensitivity to HBY 097 but not to lamivudine. Balzarini J 1997 The Journal of infectious diseases
Varicella-zoster virus thymidine kinase gene and antiherpetic pyrimidine nucleoside analogues in a combined gene/chemotherapy treatment for cancer. Balzarini J 1997 Gene therapy
Inhibition of replication of HIV in primary monocyte/macrophages by different antiviral drugs and comparative efficacy in lymphocytes. Balzarini J 1997 Journal of leukocyte biology
Models which explain the inhibition of reverse transcriptase by HIV-1-specific (thio)carboxanilide derivatives. Balzarini J 1997 Biochemical and biophysical research communications
SIV/HIV-1 hybrid virus expressing the reverse transcriptase gene of HIV-1 remains sensitive to HIV-1-specific reverse transcriptase inhibitors after passage in rhesus macaques. Balzarini J 1997 Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association
SRR-SB3, a disulfide-containing macrolide that inhibits a late stage of the replicative cycle of human immunodeficiency virus. Balzarini J 1997 Antimicrobial agents and chemotherapy
Reverse transcriptase fidelity and HIV-1 variation. Balzarini J 1997 Science (New York, N.Y.)
Characteristics of the Pro225His mutation in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase that appears under selective pressure of dose-escalating quinoxaline treatment of HIV-1. Balzarini J 1997 Journal of virology
Anti-HIV and anti-HBV activity and resistance profile of 2',3'-dideoxy-3'-thiacytidine (3TC) and its arylphosphoramidate derivative CF 1109. Balzarini J 1996 Biochemical and biophysical research communications
Analysis of inhibition of retroviral reverse transcriptase. Balzarini J 1996 Methods in enzymology
Highly favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 replication. Balzarini J 1996 Molecular pharmacology
Marked inhibitory activity of non-nucleoside reverse transcriptase inhibitors against human immunodeficiency virus type 1 when combined with (-)2',3'-dideoxy-3'-thiacytidine. Balzarini J 1996 Molecular pharmacology
Identification of novel thiocarboxanilide derivatives that suppress a variety of drug-resistant mutant human immunodeficiency virus type 1 strains at a potency similar to that for wild-type virus. Balzarini J 1996 Antimicrobial agents and chemotherapy
Differences in the inhibition of human immunodeficiency virus type 1 reverse transcriptase DNA polymerase activity by analogs of nevirapine and [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro-5"-(4"-amino-1", 2"-oxathiole-2",2"-dioxide] (TSAO). Balzarini J 1996 Molecular pharmacology
Novel L-lyxo and 5'-deoxy-5'-modified TSAO-T analogs: synthesis and anti-HIV-1 activity. Balzarini J 1996 Antiviral research
A two plasmid co-expression system in Escherichia coli for the production of virion-like reverse transcriptase of the human immunodeficiency virus type 1. Balzarini J 1996 Journal of virological methods
Potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines. Balzarini J 1996 Molecular pharmacology
Cytotoxicity of 3'-azido-3'-deoxythymidine correlates with 3'-azidothymidine-5'-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3'-azidothymidine-5'-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells. Balzarini J 1995 Biochemical pharmacology
Suppression of the breakthrough of human immunodeficiency virus type 1 (HIV-1) in cell culture by thiocarboxanilide derivatives when used individually or in combination with other HIV-1-specific inhibitors (i.e., TSAO derivatives). Balzarini J 1995 Proceedings of the National Academy of Sciences of the United States of America
Knocking out human immunodeficiency virus through non-nucleoside reverse transcriptase inhibitors used as single agents or in combinations: a paradigm for the cure of AIDS? Balzarini J 1995 Farmaco (Società chimica italiana : 1989)
Sensitivity/resistance profile of a simian immunodeficiency virus containing the reverse transcriptase gene of human immunodeficiency virus type 1 (HIV-1) toward the HIV-1-specific non-nucleoside reverse transcriptase inhibitors. Balzarini J 1995 Biochemical and biophysical research communications
Activity of various thiocarboxanilide derivatives against wild-type and several mutant human immunodeficiency virus type 1 strains. Balzarini J 1995 Antiviral research
Synthesis and anti-HIV activity of [AZT]-[TSAO-T] and [AZT]-[HEPT] dimers as potential multifunctional inhibitors of HIV-1 reverse transcriptase. Balzarini J 1995 Journal of medicinal chemistry
Differential activities of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives against different human immunodeficiency virus type 1 mutant strains. Balzarini J 1995 Antimicrobial agents and chemotherapy
Novel concepts in the treatment of human immunodeficiency virus type 1 (HIV-1) infections by HIV-1-specific reverse transcriptase inhibitors. Balzarini J 1995 Verhandelingen - Koninklijke Academie voor Geneeskunde van België
Resistance pattern of human immunodeficiency virus type 1 reverse transcriptase to quinoxaline S-2720. Balzarini J 1994 Journal of virology
Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants. Balzarini J 1994 Proceedings of the National Academy of Sciences of the United States of America
The synthesis of nucleoside 5'-O-(1,1-dithiotriphosphates). Balzarini J 1994 Journal of medicinal chemistry
Resistance of HIV-1 reverse transcriptase against [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2''-dioxide)] (TSAO) derivatives is determined by the mutation Glu138-->Lys on the p51 subunit. Balzarini J 1994 The Journal of biological chemistry
Sensitivity of (138 Glu-->Lys) mutated human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) to HIV-1-specific RT inhibitors. Balzarini J 1994 Biochemical and biophysical research communications
Comparative cytostatic activity of different antiherpetic drugs against herpes simplex virus thymidine kinase gene-transfected tumor cells. Balzarini J 1994 Molecular pharmacology
Inhibition of visna virus replication by 2',3'-dideoxynucleosides and acyclic nucleoside phosphonate analogs. Balzarini J 1993 Antimicrobial agents and chemotherapy
Knocking-out concentrations of HIV-1-specific inhibitors completely suppress HIV-1 infection and prevent the emergence of drug-resistant virus. Balzarini J 1993 Virology
Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitors. Balzarini J 1993 Proceedings of the National Academy of Sciences of the United States of America
Treatment of human immunodeficiency virus type 1 (HIV-1)-infected cells with combinations of HIV-1-specific inhibitors results in a different resistance pattern than does treatment with single-drug therapy. Balzarini J 1993 Journal of virology
Human immunodeficiency virus type 1 drug-resistance patterns with different 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives. Balzarini J 1993 Molecular pharmacology
HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptase. Balzarini J 1993 Virology
Human immunodeficiency virus type 1-specific [2',5'-bis-O-(tert- butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"- oxathiole-2",2"-dioxide)-purine analogues show a resistance spectrum that is different from that of the human immunodeficiency virus type 1-specific non-nucleoside analogues. Balzarini J 1993 Molecular pharmacology
2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2'-dioxide)pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcriptase. Balzarini J 1992 Proceedings of the National Academy of Sciences of the United States of America
[2',5'-Bis-O-(tert-butyldimethylsilyl)]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide) (TSAO) derivatives of purine and pyrimidinenucleosides as potent and selective inhibitors of human immunodeficiency virus type 1. Balzarini J 1992 Antimicrobial agents and chemotherapy
Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents. Balzarini J 1992 Molecular pharmacology
3'-C-branched 2'-deoxy-5-methyluridines: synthesis, enzyme inhibition, and antiviral properties. Balzarini J 1992 Journal of medicinal chemistry
Anti-human immunodeficiency virus effects of cationic metalloporphyrin-ellipticine complexes. Balzarini J 1992 Biochemical pharmacology
Selective inhibition of HIV replication by adriamycin in macrophages but not in lymphocytes. Balzarini J 1992 AIDS research and human retroviruses
Kinetics of inhibition of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by the novel HIV-1-specific nucleoside analogue [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5 "- (4"-amino-1",2"-oxathiole-2",2"-dioxide)thymine (TSAO-T). Balzarini J 1992 The Journal of biological chemistry
Differential inhibition of retroviral reverse transcriptase by poly(2-fluoroadenylic acid), a template analogue. Balzarini J 1991 AIDS (London, England)
5-Phosphoribosyl 1-pyrophosphate synthetase converts the acyclic nucleoside phosphonates 9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 9-(2-phosphonylmethoxyethyl)adenine directly to their antivirally active diphosphate derivatives. Balzarini J 1991 The Journal of biological chemistry
9-[(2RS)-3-fluoro-2-phosphonylmethoxypropyl] derivatives of purines: a class of highly selective antiretroviral agents in vitro and in vivo. Balzarini J 1991 Proceedings of the National Academy of Sciences of the United States of America
Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine, a potent anti-human immunodeficiency virus compound. Balzarini J 1991 Proceedings of the National Academy of Sciences of the United States of America
Potent DNA chain termination activity and selective inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxyuridine-5'-triphosphate. Balzarini J 1990 Molecular pharmacology
Differential inhibitory effects of several pyrimidine 2',3'-dideoxynucleoside 5'-triphosphates on the activities of reverse transcriptase and various cellular DNA polymerases. Balzarini J 1989 Molecular pharmacology
Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative. Balzarini J 1989 Biochemical and biophysical research communications
Differential inhibition of various deoxyribonucleic acid polymerases by Evans blue and aurintricarboxylic acid. Balzarini J 1988 European journal of biochemistry / FEBS
Fuchsin acid selectively inhibits human immunodeficiency virus (HIV) replication in vitro. Balzarini J 1988 Biochemical and biophysical research communications
Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Balzarini J 1988 Proceedings of the National Academy of Sciences of the United States of America
Alpha, beta- and beta, gamma-methylene 5'-phosphonate derivatives of 3'-azido-2',3'-dideoxythymidine-5'-triphosphate. Correlation between affinity for reverse transcriptase, susceptibility to hydrolysis by phosphodiesterases and anti-retrovirus activity. Balzarini J 1988 Biochemical pharmacology
Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV). Balzarini J 1986 International journal of cancer. Journal international du cancer
Aurintricarboxylic acid and Evans Blue represent two different classes of anionic compounds which selectively inhibit the cytopathogenicity of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus. Balzarini J 1986 Biochemical and biophysical research communications
Antiviral activity of the 3'-amino derivative of (E)-5-(2-bromovinyl)-2'-deoxyuridine. Balzarini J 1983 The Biochemical journal

Version:20241007

Using Polbase tables:

Sorting:

Tables may be sorted by clicking on any of the column titles. A second click reverses the sort order. <Ctrl> + click on the column titles to sort by more than one column (e.g. family then name).

Filtering:

It is also possible to filter the table by typing into the search box above the table. This will instantly hide lines from the table that do not contain your search text.